Foresite Capital Management IV, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
Foresite Capital Management IV, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2019$4,875,000
-8.9%
367,636
-4.7%
1.58%
+4.2%
Q2 2019$5,350,000
-76.0%
385,751
-66.8%
1.51%
-81.2%
Q1 2019$22,321,000
+29.8%
1,161,965
-3.6%
8.02%
+1.6%
Q4 2018$17,201,000
-32.9%
1,205,363
-2.1%
7.90%
-6.1%
Q3 2018$25,653,000
-12.0%
1,231,5430.0%8.41%
-15.4%
Q2 2018$29,151,000
+85.9%
1,231,543
+14.7%
9.94%
+52.8%
Q1 2018$15,681,000
-9.6%
1,073,2720.0%6.50%
-46.5%
Q4 2017$17,344,0001,073,27212.16%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders